A recent editorial in The Boston Globe overstates the effect of the Supreme Court's ruling on pre-emption in the medical-device sector because the ruling does not shield companies from lawsuits, AdvaMed President and CEO Stephen J. Ubl writes in a letter to the editor. The decision upholds federal law, and an environment that supports varying safety standards for different states would hamper innovations and patient access to life-saving devices, Ubl writes.

Related Summaries